Natural killer (NK) cell deficit in coronary artery disease: No aberrations in phenotype but sustained reduction of NK cells is associated with low-grade inflammation

Clinical and Experimental Immunology

Volumn 175, Issue 1, 2014, Pages 104-112

  Backteman, K ^a,b   Ernerudh, J ^a,b   Jonasson, L ^a,b  

^a LINKÖPING UNIVERSITY   (Sweden)

^b Centre of Surgery and Oncology   (Sweden)

Author keywords

Coronary artery disease; Cytokines; Inflammation; Leukocytes; Natural killer cell

Indexed keywords

ACETYLSALICYLIC ACID; ANTIANGINA PECTORIS AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CD56 ANTIGEN; CD57 ANTIGEN; CD69 ANTIGEN; CELL SURFACE MARKER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HLA DR ANTIGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 15; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRATE; TRIACYLGLYCEROL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HUMAN; IN VIVO STUDY; LONG TERM CARE; LOW DRUG DOSE; LYMPHOCYTE; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NATURAL KILLER CELL; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STABLE ANGINA PECTORIS; T LYMPHOCYTE; TRIACYLGLYCEROL BLOOD LEVEL;

CORONARY ARTERY DISEASE; CYTOKINES; INFLAMMATION; LEUKOCYTES; NATURAL KILLER CELL;

ADULT; CORONARY ARTERY DISEASE; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; INTERLEUKIN-6; KILLER CELLS, NATURAL; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION;

EID: 84888874883     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12210     Document Type: Article

References (33)

1. Shereck E, Satwani P, Morris E, Cairo MS. Human natural killer cells in health and disease. Pediatr Blood Cancer 2007; 49:615-623.
2. Yokoyama WM, Kim S, French AR. The dynamic life of natural killer cells. Annu Rev Immunol 2004; 22:405-429.
3. Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol 2001; 22:633-640.
4. Gayoso I, Sanchez-Correa B, Campos C etal. Immunosenescence of human natural killer cells. J Innate Immun 2011; 3:337-343.
5. Lopez-Verges S, Milush JM, Pandey S etal. CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset. Blood 2010; 116:3865-3874.
6. Radaev S, Sun PD. Structure and function of natural killer cell surface receptors. Annu Rev Biophys Biomol Struct 2003; 32:93-114.
7. Bjorkstrom NK, Riese P, Heuts F etal. Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. Blood 2010; 116:3853-3864.
8. Jonasson L, Backteman K, Ernerudh J. Loss of natural killer cell activity in patients with coronary artery disease. Atherosclerosis 2005; 183:316-321.
9. Hak L, Mysliwska J, Wieckiewicz J etal. NK cell compartment in patients with coronary heart disease. Immun Ageing 2007; 4:3.
10. Hou N, Zhao D, Liu Y etal. Increased expression of T cell immunoglobulin- and mucin domain-containing molecule-3 on natural killer cells in atherogenesis. Atherosclerosis 2012; 222:67-73.
11. Backteman K, Andersson C, Dahlin LG, Ernerudh J, Jonasson L. Lymphocyte subpopulations in lymph nodes and peripheral blood: a comparison between patients with stable angina and acute coronary syndrome. PLOS ONE 2012; 7:e32691.
12. Galkina E, Ley K. Immune and inflammatory mechanisms of atherosclerosis (*). Annu Rev Immunol 2009; 27:165-197.
13. Perricone R, Perricone C, De Carolis C, Shoenfeld Y. NK cells in autoimmunity: a two-edged weapon of the immune system. Autoimmun Rev 2008; 7:384-390.
14. Tobin AM, Lynch L, Kirby B, O'Farrelly C. Natural killer cells in psoriasis. J Innate Immun 2011; 3:403-410.
15. Zhang B, Yamamura T, Kondo T, Fujiwara M, Tabira T. Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J Exp Med 1997; 186:1677-1687.
16. Leavenworth JW, Wang X, Wenander CS, Spee P, Cantor H. Mobilization of natural killer cells inhibits development of collagen-induced arthritis. Proc Natl Acad Sci USA 2011; 108:14584-14589.
17. Flodstrom-Tullberg M, Bryceson YT, Shi FD, Hoglund P, Ljunggren HG. Natural killer cells in human autoimmunity. Curr Opin Immunol 2009; 21:634-640.
18. Lurati A, Bertani L, Marrazza M, Re KA, Bompane D, Scarpellini M. NK cell count as predictor of clinical response in patients with rheumatoid arthritis treated with rituximab. Biologics 2012; 6:83-87.
19. Takahashi K, Miyake S, Kondo T etal. Natural killer type 2 bias in remission of multiple sclerosis. J Clin Invest 2001; 107:R23-29.
20. Yamaguchi Y, Takahashi H, Satoh T etal. Natural killer cells control a T-helper 1 response in patients with Behcet's disease. Arthritis Res Ther 2010; 12:R80.
21. Pandya AD, Al-Jaderi Z, Hoglund RA etal. Identification of human NK17/NK1 cells. PLOS ONE 2011; 6:e26780.
22. Backteman K, Ernerudh J. Biological and methodological variation of lymphocyte subsets in blood of human adults. J Immunol Methods 2007; 322:20-27.
23. Varbo A, Benn M, Tybjaerg-Hansen A, Jorgensen AB, Frikke-Schmidt R, Nordestgaard BG. Remnant cholesterol as a causal risk factor for ischemic heart disease. J Am Coll Cardiol 2013; 61:427-436.
24. Satoh A, Adachi H, Tsuruta M etal. High plasma level of remnant-like particle cholesterol in the metabolic syndrome. Diabetes Care 2005; 28:2514-2518.
25. Lutz CT, Karapetyan A, Al-Attar A etal. Human NK cells proliferate and die in vivo more rapidly than T cells in healthy young and elderly adults. J Immunol 2011; 186:4590-4598.
26. Lutz CT, Quinn LS. Sarcopenia, obesity, and natural killer cell immune senescence in aging: altered cytokine levels as a common mechanism. Aging (Albany NY) 2012; 4:535-546.
27. Lynch LA, O'Connell JM, Kwasnik AK, Cawood TJ, O'Farrelly C, O'Shea DB. Are natural killer cells protecting the metabolically healthy obese patient? Obesity (Silver Spring) 2009; 17:601-605.
28. Evans JH, Horowitz A, Mehrabi M etal. A distinct subset of human NK cells expressing HLA-DR expand in response to IL-2 and can aid immune responses to BCG. Eur J Immunol 2011; 41:1924-1933.
29. Jost S, Quillay H, Reardon J etal. Changes in cytokine levels and NK cell activation associated with influenza. PLOS ONE 2011; 6:e25060.
30. Ammirati E, Cianflone D, Banfi M etal. Circulating CD4+CD25hiCD127lo regulatory T-cell levels do not reflect the extent or severity of carotid and coronary atherosclerosis. Arterioscler Thromb Vasc Biol 2010; 30:1832-1841.
31. Ammirati E, Cianflone D, Vecchio V etal. Effector memory T cells are associated with atherosclerosis in humans and animal models. J Am Heart Assoc 2012; 1:27-41.
32. Caligiuri G, Paulsson G, Nicoletti A, Maseri A, Hansson GK. Evidence for antigen-driven T-cell response in unstable angina. Circulation 2000; 102:1114-1119.
33. Ammirati E, Vermi AC, Cianflone D etal. Expansion of T-cell receptor zeta dim effector T cells in acute coronary syndromes. Arterioscler Thromb Vasc Biol 2008; 28:2305-2311.